In summary, we have generated a comprehensive multiomic atlas of the cellular heterogeneity in human kidney disease and identified druggable signalling pathways by which an ICAM1+ inflammatory tubular cell subset may mediate tubulointerstitial inflammation and fibrosis. Here, ICAM1 is linked to kidney disorder.